# Oral Care With 3% Hydrogen Peroxide (Oroxid®) in ICU - Effects on the Lower Airway Microbial Colonisation

> **NCT06045429** · PHASE4 · RECRUITING · sponsor: **Charles University, Czech Republic** · enrollment: 160 (estimated)

## Conditions studied

- VAP - Ventilator Associated Pneumonia

## Interventions

- **DRUG:** Oroxid®
- **DRUG:** Chlorhexidine mouthwash

## Key facts

- **NCT ID:** NCT06045429
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06045429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06045429, "Oral Care With 3% Hydrogen Peroxide (Oroxid®) in ICU - Effects on the Lower Airway Microbial Colonisation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06045429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*